|
GGA3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.73350000021166E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.7937999997073E-07 |
| Normal-vs-Stage2 |
9.936500E-03 |
| Normal-vs-Stage3 |
1.003060E-03 |
| Normal-vs-Stage4 |
3.080400E-03 |
| Stage1-vs-Stage2 |
7.108600E-01 |
| Stage1-vs-Stage3 |
3.353400E-01 |
| Stage1-vs-Stage4 |
5.228400E-01 |
| Stage2-vs-Stage3 |
7.549400E-01 |
| Stage2-vs-Stage4 |
8.842800E-01 |
| Stage3-vs-Stage4 |
8.632400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.76079999997447E-06 |
| Normal-vs-AfricanAmerican |
2.43779999999916E-05 |
| Normal-vs-Asian |
3.639600E-03 |
| Caucasian-vs-AfricanAmerican |
4.052200E-02 |
| Caucasian-vs-Asian |
1.056390E-03 |
| AfricanAmerican-vs-Asian |
2.424300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.170160E-04 |
| Normal-vs-Female |
1.77549996926984E-09 |
| Male-vs-Female |
7.599200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.295840E-01 |
| Normal-vs-Age(41-60Yrs) |
1.19980000001796E-06 |
| Normal-vs-Age(61-80Yrs) |
4.38520000001219E-06 |
| Normal-vs-Age(81-100Yrs) |
1.392390E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.939800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.458000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.987000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.820400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.105800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.614800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.92220050776859E-10 |
| Normal-vs-Grade 2 |
4.2958000000537E-06 |
| Normal-vs-Grade 3 |
7.97009999999876E-05 |
| Normal-vs-Grade 4 |
1.537080E-03 |
| Grade 1-vs-Grade 2 |
1.094480E-02 |
| Grade 1-vs-Grade 3 |
1.739980E-03 |
| Grade 1-vs-Grade 4 |
1.324400E-02 |
| Grade 2-vs-Grade 3 |
4.906200E-01 |
| Grade 2-vs-Grade 4 |
9.849600E-01 |
| Grade 3-vs-Grade 4 |
5.935000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.57529999950712E-07 |
| Normal-vs-ccB subtype |
2.387900E-04 |
| ccA subtype-vs-ccB subtype |
7.805200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.11349999998289E-06 |
| Normal-vs-N1 |
4.434000E-02 |
| N0-vs-N1 |
8.182000E-01 |
|
|
